Breast Cancer Trial, Recruiting NCT06297265 Sponsor: University of Southern California Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06297265
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women with natural (non-reconstructed) breasts who have been diagnosed with localised breast cancer and have already had a lumpectomy (surgery to remove the tumour while keeping the breast)
  • People who will be receiving whole-breast radiation therapy, with or without radiation to nearby lymph nodes, using a standard or moderately shortened radiation schedule
  • People aged 18 years or older
  • People who are able to understand and are willing to sign a written consent form in English or Spanish

Who may not be able to join:

  • People who have a chronic inflammatory condition or a connective tissue disorder — such as scleroderma, lupus, rheumatoid arthritis, or fibromyalgia — as these conditions may affect how the body responds to radiation
  • People with serious ongoing health conditions that are not well managed, including active infections, heart failure, unstable chest pain, irregular heartbeat, or mental health or personal circumstances that could make it difficult to follow the trial requirements
  • People who are unable to provide written consent in English or Spanish
  • People whose radiation treatment plan involves a highly condensed (ultra-hypofractionated) schedule, or who are receiving radiation to only part of the breast or to the chest wall rather than the whole breast

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: May L Tao, MD, University of Southern California

Phone: 323-865-0451

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 May 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of compliance of MLD breast massage sessions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov